droloxifene
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Estrogen receptorMODULATOR
Estrogen receptor modulator
SERM, development stopped as ineffective compared to tamoxifen.
Chemistry & pharmacology
Loading structure…
SMILES
CC/C(=C(/c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1- Mol. weight
- 387.52 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL487 ↗
Also known as
- 3-hydroxytamoxifen
- 3-hydroxytamoxifen
- 3-hydroxytamoxifen
- 3-hydroxytamoxifen citrate
- droloxifene
- droloxifene
- droloxifene
- droloxifene citrate
- e-droloxifene
- e-droloxifene
- fk435
- fk 435
- fk-435
- fk-435
- fk-435
- k-060
- k-060
- k-060e
- k-060e
- k-21060e
- k-21060e
- meta-hydroxytamoxifen
- phenol, 3-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)-, (e)-